TrialThe British journal of dermatology2019

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.

J I Silverberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.